Mutant TP53 switches therapeutic vulnerability during gastric cancer progression within interleukin-6 family cytokines.
Huber A, Allam AH, Dijkstra C, Thiem S, Huynh J, Poh AR, Konecnik J, Jacob SP, Busuttil R, Liao Y, Chisanga D, Shi W, Alorro MG, Forrow S, Tauriello DVF, Batlle E, Boussioutas A, Williams DS, Buchert M, Ernst M, Eissmann MF.
Huber A, et al. Among authors: huynh j.
Cell Rep. 2024 Aug 27;43(8):114616. doi: 10.1016/j.celrep.2024.114616. Epub 2024 Aug 9.
Cell Rep. 2024.
PMID: 39128004
Free PMC article.